THIS paper is a report on a controlled study of the effects of a new sympathomimetic drug on patients with coronary arteriosclerosis. The drug, l-cyclohexyl-2-methylaminopropane, is used commercially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback